Dr. Dima is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
825 Eastlake Ave E
Seattle, WA 98109Phone+1 206-520-5000
Education & Training
- Tufts Medical CenterResidency, Internal Medicine, 2018 - 2021
- University of AthensClass of 2017
Certifications & Licensure
- WA State Medical License 2024 - 2027
- OH State Medical License 2021 - 2025
- MA State Medical License 2018 - 2021
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
Publications & Presentations
PubMed
- Comparison of Standard-of-Care Idecabtagene Vicleucel and Ciltacabtagene Autoleucel in Relapsed/Refractory Multiple Myeloma.Doris K Hansen, Lauren C Peres, Danai Dima, Alicia Richards, Leyla Shune
Journal of Clinical Oncology. 2025-02-18 - Clonal hematopoiesis in large granular lymphocytic leukemia.Naomi Kawashima, Carmelo Gurnari, Carlos Bravo-Perez, Yasuo Kubota, Simona Pagliuca
Leukemia. 2025-02-01 - Illuminating the Shadows: Innovation in Advanced Imaging Techniques for Myeloma Precursor Conditions.Kara I Cicero, Rahul Banerjee, Mary Kwok, Danai Dima, Andrew J Portuguese
Diagnostics. 2025-01-18
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: